View Item 

Show simple item record

Evidence-Based Medicine (EBM) in Practice: Understanding Tests of Heterogeneity in Metaanalysis

dc.contributor.authorSchoenfeld, Philip S.en_US
dc.contributor.authorLoftus, Edward V.en_US
dc.date.accessioned2010-06-01T19:56:31Z
dc.date.available2010-06-01T19:56:31Z
dc.date.issued2005-06en_US
dc.identifier.citationSchoenfeld, Philip S.; Loftus, Edward V. (2005). "Evidence-Based Medicine (EBM) in Practice: Understanding Tests of Heterogeneity in Metaanalysis." The American Journal of Gastroenterology 100(6): 1221-1223. <http://hdl.handle.net/2027.42/73071>en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73071
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15929747&dopt=citationen_US
dc.format.extent51744 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing, Inc.en_US
dc.rights2005 by the American College of Gastroenterologyen_US
dc.titleEvidence-Based Medicine (EBM) in Practice: Understanding Tests of Heterogeneity in Metaanalysisen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Gastroenterology, University of Michigan School of Medicine and Veterans Affairs Center for Excellence in Health Services Research, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDivision of Gastroenterology, Mayo Clinic, Rochester, Minnesotaen_US
dc.identifier.pmid15929747en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73071/1/j.1572-0241.2005.50452.x.pdf
dc.identifier.doi10.1111/j.1572-0241.2005.50452.xen_US
dc.identifier.sourceThe American Journal of Gastroenterologyen_US
dc.identifier.citedreferenceCosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005; 54: 237 – 41.en_US
dc.identifier.citedreferencePearson DC, May GR, Fick GH, et al. Azathioprine and 6-mercaptopurine in Crohn's disease: A meta-analysis. Ann Intern Med 1995; 122: 132 – 42.en_US
dc.identifier.citedreferenceSchoenfeld P, Cook D, Hamilton S, et al. An evidence-based approach to gastroenterology therapy. Gastroenterology 1999; 116: 1230 – 37.en_US
dc.identifier.citedreferenceOxman AD, Cook DJ, Guyatt G. for the Evidence Based Medicine Working Group. Users' guide to the medical literature. VI. How to use an overview. JAMA 1994; 272: 1367 – 71.en_US
dc.identifier.citedreferenceNorgard B, Pedersen L, Fonanger K, et al. Azathioprine, mercaptopurine and birth outcome: A population-based study. Aliment Pharmacol Ther 2003; 17: 827 – 34.en_US
dc.identifier.citedreferenceMarkowitz J, Grancher K, Kohn N, et al. for the Pediatric 6MP Collaborative Group. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119: 895 – 902.en_US
dc.identifier.citedreferenceAkobeng AK, Gardener E. Cochrane Inflammatory Bowel Disease Group. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease. Cochrane Database Syst Rev 2005, 1.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1572-0241.2005.50452.x.pdf
Size:
50.53KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.